MedTrace Logo

Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Nail Psoriasis

NCT03757364 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2018-11-28

No results posted yet for this study

Summary

The primary aim of the study is to assess the effect of methotrexate on the development of distal interphalangeal joint extensor tendon enthesopathy.

Conditions

  • Nail Psoriasis

Interventions

DRUG

Methotrexate

Methotrexate in the treatment of distal interphalangeal joint extensor tendon enthesopathy in patients with nail psoriasis

Sponsors & Collaborators

  • Ryszard Górecki

    lead OTHER

Principal Investigators

  • Magdalena Krajewska-Włodarczyk, PhD · University of Warmia and Mazury

Eligibility

Min Age
34 Years
Max Age
57 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-07
Primary Completion
2018-09-30
Completion
2018-09-30
FDA Drug
Yes

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03757364 on ClinicalTrials.gov